fate therapeutics stock price target

The average price target is 103866 which means analysts. In terms of how Fate Therapeutics Inc.

Fate Therapeutics Share Price Usd0 001

The company has an average price target of 9325 with a high of 12200 and.

. Fate Therapeutics IL-15 armored CAR-NK construct targeting CD19. 2075 -069 -324 As of 1054AM. Fate Therapeutics Stock Forecast 05-03-2022.

The Company is focused on the development of programmed cellular. According to analysts consensus price target of 8722 Fate Therapeutics has a forecasted upside of 2676 from its current price of 2373. The Fate Therapeutics stock prediction results are shown below and presented as a graph table and text information.

According to the issued ratings of 9 analysts in the last year the consensus rating for Fate Therapeutics stock is Buy based on the current 2 hold ratings and 7 buy ratings for. Sign in to your SmartPortfolio to see more analyst recommendations. Fate Therapeutics reported interim results from 14 patients treated with FT596 an off-the-shelf immunotherapy made of natural killer cells engineered to target CD19.

Stock Price Forecast. On average analysts give the stock a Strong Buy rating. ET by Tomi Kilgore Fate Therapeutics stock price target raised to 65 from 40 at Truist.

Fate Therapeutics stock forecasts are adjusted once a day. HC Wainwright dropped their price target on Fate Therapeutics from 12200 to 11500 and set a buy rating on the stock in a research report on Friday March 4th. Is 1761 for 2026.

Nasdaq REAL TIME 327 PM EDT 051222. All analysts rate this stock as a buy with a low price target of 32 which is more than double the current. 1y Target Est 8626 Fair Value is the appropriate price for the shares of a company based on its earnings and growth rate also interpreted as when PE Ratio Growth Rate.

In comparison to the median Healthcare stock FATEs pricesales ratio is 11793 higher now standing at 1452. May 6 2022 308 pm. The average price target is 000 with a high estimate of 000 and a low estimate of 000.

The average price target is 107533 which means analysts expect. This price target is based on 9 analysts offering 12 month price targets for Fate Therapeutics in the last 3 months. 65 Day Avg Vol 1330184.

Wall Street is positive on Fate Therapeutics Inc FATE. Fate Therapeutics Inc. Long term Fate Therapeutics stock forecast for 2022 2023 1 year - 2025 - 2027 5 year - 2030 and 2032 10 year Forecast for 2022 Apr.

Wall Street is positive on Fate Therapeutics Inc. In the last 3 months 4 analysts have offered 12-month price targets for Fate Therapeutics. 7 2020 at 718 am.

Fate Therapeutics stock price target raised to 88 from 55 at Wedbush Dec. Over the past 96 months FATEs priceearnings ratio has gone down 256. The average price target is 8722 with a high forecast of 000 and a low.

FATE has a greater upside potential average analyst target price relative to current price than 149379 of stocks in the mid market cap category. Forecast target price for 05-03-2022. 47 rows Close price at the end of the last trading day Friday 6th May 2022 of.

Based On Fundamental Analysis. Is a clinical-stage biopharmaceutical company. Negative dynamics for Fate Therapeutics shares will prevail with possible.

According to 26 stock analysts the average 12-month stock price forecast for FATE stock is 8799 which predicts an increase of 26329. FATE Fate Therapeutics Inc. 5 Wall Street analysts that have issued a 1 year FATE price target the average FATE price target is 8720 with the highest FATE stock price forecast at 11500 and the.

Stock Price Forecast The 19 analysts offering 12-month price forecasts for Fate Therapeutics Inc have a median target of 9000 with a high estimate of 13500 and a low estimate of 4200. FATE stock forecast and price target. Amount of Analyst Coverage.

Is 3589 for 2023 Mar. On average analysts give the stock a Strong Buy rating. Ad Our Strong Buys Double the SP.

Fate Therapeutics Potential Catalysts Ahead Nasdaq Fate Seeking Alpha